Manulife (Manufacturers Life Insurance)’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$59.3K Sell
13,143
-796
-6% -$3.59K ﹤0.01% 2864
2025
Q1
$61.8K Buy
13,939
+121
+0.9% +$536 ﹤0.01% 2800
2024
Q4
$108K Sell
13,818
-268
-2% -$2.1K ﹤0.01% 2803
2024
Q3
$185K Sell
14,086
-336
-2% -$4.42K ﹤0.01% 2696
2024
Q2
$174K Sell
14,422
-253
-2% -$3.06K ﹤0.01% 2655
2024
Q1
$239K Sell
14,675
-907
-6% -$14.7K ﹤0.01% 2515
2023
Q4
$106K Hold
15,582
﹤0.01% 2798
2023
Q3
$84.9K Hold
15,582
﹤0.01% 2857
2023
Q2
$106K Sell
15,582
-532
-3% -$3.61K ﹤0.01% 2828
2023
Q1
$80.7K Hold
16,114
﹤0.01% 2787
2022
Q4
$78.6K Buy
16,114
+1,371
+9% +$6.69K ﹤0.01% 2853
2022
Q3
$213K Sell
14,743
-332
-2% -$4.79K ﹤0.01% 2554
2022
Q2
$228K Sell
15,075
-240
-2% -$3.63K ﹤0.01% 2571
2022
Q1
$182K Sell
15,315
-3,905
-20% -$46.4K ﹤0.01% 2809
2021
Q4
$312 Buy
19,220
+364
+2% +$6 ﹤0.01% 2585
2021
Q3
$538K Sell
18,856
-1,341
-7% -$38.3K ﹤0.01% 2237
2021
Q2
$683K Buy
20,197
+2,412
+14% +$81.6K ﹤0.01% 2219
2021
Q1
$538K Sell
17,785
-788
-4% -$23.8K ﹤0.01% 2223
2020
Q4
$920K Buy
18,573
+733
+4% +$36.3K ﹤0.01% 1872
2020
Q3
$685K Sell
17,840
-287
-2% -$11K ﹤0.01% 1841
2020
Q2
$828K Buy
18,127
+2,774
+18% +$127K ﹤0.01% 1709
2020
Q1
$401K Buy
15,353
+2,485
+19% +$64.9K ﹤0.01% 1935
2019
Q4
$402K Sell
12,868
-599
-4% -$18.7K ﹤0.01% 2178
2019
Q3
$347K Buy
13,467
+378
+3% +$9.74K ﹤0.01% 2235
2019
Q2
$299K Buy
+13,089
New +$299K ﹤0.01% 2367